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Parkinson’s disease (PD) adversely affects timing abilities. Beat-based timing is a mechanism that times events relative to a regular interval, such as the “beat” in musical rhythm,
and is impaired in PD. It is unknown if dopaminergic medication influences beat-based
timing in PD. Here, we tested beat-based timing over two sessions in participants with
PD (OFF then ON dopaminergic medication) and in unmedicated control participants.
People with PD and control participants completed two tasks. The first was a discrimination task in which participants compared two rhythms and determined whether they
were the same or different. Rhythms either had a beat structure (metric simple rhythms)
or did not (metric complex rhythms), as in previous studies. Discrimination accuracy was
analyzed to test for the effects of beat structure, as well as differences between participants with PD and controls, and effects of medication (PD group only). The second task
was the Beat Alignment Test (BAT), in which participants listened to music with regular
tones superimposed, and responded as to whether the tones were “ON” or “OFF” the
beat of the music. Accuracy was analyzed to test for differences between participants
with PD and controls, and for an effect of medication in patients. Both patients and
controls discriminated metric simple rhythms better than metric complex rhythms.
Controls also improved at the discrimination task in the second vs. first session, whereas
people with PD did not. For participants with PD, the difference in performance between
metric simple and metric complex rhythms was greater (sensitivity to changes in simple
rhythms increased and sensitivity to changes in complex rhythms decreased) when ON
vs. OFF medication. Performance also worsened with disease severity. For the BAT, no
group differences or effects of medication were found. Overall, these findings suggest
that timing is impaired in PD, and that dopaminergic medication influences beat-based
and non-beat-based timing differently. Judging the beat in music does not appear to be
affected by PD or by dopaminergic medication.
Keywords: beat perception, rhythm, timing, Parkinson’s disease, dopamine
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(control participants were better at recognizing that beat-based
rhythms indeed had a beat than they were at recognizing that
non-beat-based rhythms did not have a beat). As both groups had
a small sample size (n = 9) and there was high variability between
subjects, a real group difference in beat-based timing could have
been missed. The study did find a small effect of dopaminergic
medication: responses were faster when ON vs. OFF medication,
and those responses were more accurate (though not statistically significantly). The task required explicit detection of beat
structure in rhythms, similar to the Beat Alignment Test (BAT)
in the present study. This explicit nature differs from the rhythm
discrimination task used previously (12) and in the current study,
for which an implicit influence of beat-based timing is expected:
metric simple (beat-based) rhythms should elicit better performance than metric complex (non-beat-based rhythms), but no
explicit awareness of the beat is required or assessed. Thus, there
is mixed evidence for the influence of dopaminergic medication
on timing in PD and limited evidence for its influence on beatbased timing in particular.
The uncertainty regarding dopaminergic medication’s influence on timing is partly related to the uncertainty regarding the
extent to which cognitive deficits in PD (including timing) are
associated with dopamine and would thus be modulated by dopaminergic medication. Besides deficient dopamine, other factors
also contribute to cognitive deficits in the disease, including structural changes to the brain (18, 19), and accumulation of amyloid
plaques and tau protein (20, 21). Moreover, the role of dopamine,
and influence of dopaminergic medication, in cognition is variable, as previous studies show both improvement and worsening
of different cognitive functions by medication, depending on task
demands and individual differences in baseline dopamine levels
(22, 23), as well as side of motor symptom onset (24).
The current study investigated the role of dopaminergic medication on beat-based timing in individuals with PD. We tested
participants with PD on two beat perception tasks in two sessions:
OFF and ON medication. We also tested control participants in
two sessions, but did not give them medication, to assess practice
effects. The two tasks were a rhythm discrimination task and the
BAT [from the Goldsmiths Musical Sophistication Index; (25)].
In the discrimination task, participants decided whether two
rhythms were the same or different. In several studies, the discrimination task has elicited better performance for metric simple rhythms (beat-based), compared to metric complex rhythms
(non-beat-based) (5, 12, 26–28). This “beat-based advantage” is
thought to depend on the beat-based timing (or relative timing)
mechanism, which is thought to, in turn, depend on basal ganglia
function (12). The second task, the BAT, presents excerpts of real
music clips with a sequence of regular tones added to the music.
The tones are either aligned or misaligned with the beat of the
music, and participants decide whether the tones were on or off
the beat of the music.
Both tasks assess beat perception; however, beat perception
in the discrimination task arises solely on temporal information, without the rich variety of acoustic cues present in real
music. The discrimination task also requires a comparison
of two separately presented rhythms, introducing a working
memory component. We hypothesized that if beat-based timing

INTRODUCTION
Parkinson’s disease (PD) causes progressive motor and cognitive
deficits, including deficits in timing (1, 2). Timing deficits in PD
are likely related to dopaminergic dysfunction in the basal ganglia
as the striatal dopaminergic system is known to be involved in
timing (3, 4). One particular type of timing, beat-based timing,
involves the timing of events relative to a regular interval, or a
“beat,” such as in musical rhythm. In music, the beat is the regular,
perceived emphasis to which listeners tend to synchronize their
movements (e.g., by clapping their hands or tapping their feet).
Beat-based timing activates the basal ganglia, among other cortical and subcortical regions of the motor system (5–9). There is
mixed evidence regarding whether the basal ganglia have a specific
role in beat-based timing compared to other types of timing. One
study found that both beat-based (relative) and non-beat-based
(absolute) timing was worse in participants from three clinical
populations (not including PD) with impaired basal ganglia
function, compared to control participants (10). This result was
interpreted as supporting the “unified model” of timing (11), in
which the basal ganglia play a central role in all types of timing,
and not specifically in beat-based timing. However, another study
found that patients with PD had a selective deficit in beat-based
timing (12). Although both patients and controls discriminated
metric simple (beat-based) rhythms more accurately than metric
complex (non-beat-based) rhythms, patients with PD were significantly less accurate than controls for metric simple rhythms,
but not for metric complex rhythms. This finding suggested a
selective role for the basal ganglia in beat-based timing. However,
all patients in the study were tested while ON dopaminergic
medication, thus the influence of dopamine and dopaminergic
medication on beat-based timing is not well understood.
For timing in PD generally, there is mixed evidence for
dopaminergic medication’s influence. Dopaminergic medication improves timing production of participants with PD in
a task using intervals in the range of 30–120 s, but not in the
range of 250–2000 ms (13). In addition, participants with PD
perform more similarly to control participants (with less timing
variability) on a set of timing tasks while ON medication than
while OFF (14). A study using behavioral and positron emission
tomography (PET) found no effect of medication on PD patients’
ability to synchronize their tapping with an isochronous tones,
although dopaminergic denervation was related to tapping accuracy (15). Another neuroimaging study (16) found that, although
dopamine replacement therapy did not improve performance of
patients with PD in a motor timing task, neural activity increased
toward the level of controls in the dorsal putamen and supplementary motor area [regions associated with beat perception; (5)]
during task performances. One study investigated the influence
of dopaminergic medication on how well participants with PD
detected beat structure in rhythms (17). Participants with PD
and controls decided whether rhythms (that were either beatbased or non-beat-based) had a beat. Participants with PD did
not significantly differ from controls, for either type of rhythm,
although numerically participants with PD were worse than
control participants at the task, and showed less difference in
performance between beat-based and non-beat-based rhythms
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depends on basal ganglia function, and is thus impaired in PD,
dopaminergic medication should improve discrimination of
metric simple rhythms (but not metric complex rhythms).
In contrast to the discrimination task, the BAT assesses beat
perception in the context of real music, meaning that there are
numerous musical features, unrelated to timing, that emphasize the beat (e.g., bass timbres or certain chord changes are
more likely to occur on the beat). Beat perception in the BAT
therefore does not rely solely on timing cues. The BAT has,
to the best of our knowledge, not been used in the context
of PD. If participants with PD perform worse than controls,
it would provide converging evidence for a deficit in beat
perception and suggest that other musical cues to the beat do
not sufficiently compensate for that timing deficit. Similarly, if
dopaminergic medication improves BAT performance in participants with PD, then beat perception in real musical contexts
is likely dependent on basal ganglia function. Alternatively, if
the groups do not differ, and/or there is no effect of medication on BAT performance, then beat perception arising from
non-temporal cues likely does not rely on intact dopaminergic
function of the basal ganglia.

FIGURE 1 | Waveforms of examples of the two types of rhythmic
sequences, metric simple and metric complex, used as stimuli in the
rhythm discrimination task. Numbers indicate the relative duration of
intervals (1 = 200, 233, or 267 ms). Lines indicate tone onsets, and arrows
indicate beat positions in the metric simple condition.

TABLE 1 | Trials for rhythm discrimination task.
Metric simple
First rhythm
31413
41331
112314
112422
211224
222114
223113
311322
1122114
1123113
2113113
2211114
3121113
3122112
4221111

MATERIALS AND METHODS
Participants

Second rhythm

43131

112224

Metric complex
First rhythm
33141
41232
122142
124113
132321
214311
323211
412212
1132212
1314111
2123211
2141211
2331111
3114111
3221112

Second rhythm

312321
124311
323121
412221

Participants with PD were recruited from the St. Louis, MO,
USA region to participate in an ongoing study investigating
interventions for improving gait in PD. The data from these
participants (n = 72, 30 female, mean age 66.8 years, SD = 9.4,
mean of 2.18 years of musical training) are the baseline data,
collected before any intervention, and only from participants
who were taking dopaminergic medication at the time of testing. Controls (n = 70, 50 female, mean age 67.6 years, SD = 9.0,
mean of 3.37 years of musical training) were recruited from the
London, ON, Canada region. All participants scored at least
27 on the Mini Mental State Examination. Group differences
in age and mean years of musical training were not statistically
significant (p > 0.05). Participants’ highest achieved education
levels were scored from 1 (high school) to 4 (advanced degree),
and the groups did not differ on this measure (mean PD education = 2.79, SD = 1.05, mean control education = 2.90, SD = 1.07,
p > 0.05). All participants provided informed, written consent in
accord with procedures approved by the respective ethics boards
at Western University and Washington University School of
Medicine.

For the BAT [from the Goldsmiths Musical Sophistication
Index; (25)], stimuli were 17 excerpts of music in which an isochronous tone sequence was embedded. The tone sequence could
either be aligned with the beat of the music (“on beat,” four trials),
faster or slower than the musical beat (period-shifted, eight trials), or at the same beat rate, but misaligned to the musical beat
(phase-shifted, five trials).

Stimuli

Procedure

2112114
3121131
1322112

1311411
1223211

1314111
3212112

Empty cells indicate that the second rhythm was the same as the first.
Numbers indicate relative duration of intervals (1 = 200, 233, or 267 ms).

For the rhythm discrimination task, two types of rhythms were
used: metric simple and metric complex (see Figure 1). The
stimuli are described in detail elsewhere (12). Both types are
composed of intervals that are related by small integer-ratios, and
were presented in one of three tempi, corresponding to the shortest interval duration (i.e., rhythms consisted of interval durations
of 1, 2, 3, and 4, in which “1” was equal to 200, 233, or 267 ms, “2”
was twice the duration of “1,” etc.). The trials used were a subset of
the trials used in a previous study (12), and are listed in Table 1.
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Testing consisted of completing each task twice in the same day,
with between 30 and 90 min separating the two testing sessions.
Participants with PD were OFF medication in the first session
(participants were asked to withhold all anti-Parkinson’s medication for at least 12 h prior to the session) and ON medication
in the second session [all participants with PD were regularly
taking levodopa (l-DOPA), typically in combination with carbidopa, except one participant who was taking rasagiline and
pramipexole, one who was taking amantadine and pramipexole,
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and another who was taking ropinirole]. Between testing sessions, participants completed the MMSE and a questionnaire
about their musical training. Additionally, participants with PD
completed the Movement Disorders Society Unified Parkinson’s
Disease Rating Scale [MDS-UPDRS; Ref. (29)].
Participants completed both tasks on laptops. Auditory
stimuli were presented via headphones, and instruction text was
presented on the laptop display. For the rhythm discrimination
task, participants heard three consecutive rhythms (see Stimuli)
and responded whether they thought the final rhythm was the
same as the first two (which were always identical). During the
two presentations of the first rhythm, the text “Original rhythm:
First listen” and “Original rhythm: Second listen” were displayed,
respectively, in white text. During presentation of the final,
comparison, rhythm, the text “SECOND rhythm” was displayed
in red text. Following presentation of the second rhythm, “Was
the SECOND rhythm the same or different? If same, press (S). If
different, press (D)” was displayed in white text. Participants then
indicated whether they thought the second rhythm was the same
as or different from the original rhythm. Four practice trials were
completed before testing.
For the BAT, participants completed 17 trials (see Stimuli) in
random order. Participants were given verbal instructions to listen to each music excerpt and to respond whether the embedded
tone sequence was “ON” or “OFF” the beat of the music. During
listening, the laptop display read “Please Listen,” and following
each excerpt, it read “Are the tones on or off the beat? Press “y”
for YES or “n” for NO on the keyboard.” Three practice trials were
completed before testing.

Beat alignment test scores (proportion of correct trials) were
analyzed in a 2 × 2 mixed ANCOVA with the between-subjects
factor of group (control vs. PD) and within-subject factor of
session (first vs. second session, also corresponding to OFF vs.
ON medication for the participants with PD), and musical training and education (both mean-centered, separately for the two
groups) as covariates.

RESULTS
Rhythm Discrimination

Participants with PD were worse than control participants at
discriminating rhythms [main effect of group, F(1,136) = 10.86,
p = 0.001, η2p = 0.074]. In the second session, control participants
performed better than in the first session, and participants with
PD did not show this improvement [a statistical trend toward
an interaction of group and session, F(1,136) = 3.31, p = 0.071,
η2p = 0.024], confirmed by follow-up paired t tests comparing average scores within each session for healthy controls, [t(68) = 2.22,
p = 0.030, and for participants with PD, p > 0.05], as shown in
Figure 2. Overall, discrimination was better for metric simple
rhythms than for metric complex rhythms [main effect of metricality, F(1,136) = 36.50, p < 0.001, η2p = 0.212 ]. This effect of
metricality was present for both groups in both sessions (p < 0.05,
in all cases), as shown in Figure 3. Regarding musical training,
there was a statistical trend toward those more training being
better at discriminating rhythms [F(1,136) = 3.77, p = 0.054,
η2p = 0.027 ]. Although education level was not a significant
covariate, there was a trend toward education interacting with
metricality [F(1,136) = 3.63, p = 0.059, η2p = 0.026 ]. Follow-up
comparisons of these data show that trends were in opposite
directions: those with more education tended to do better with
metric complex rhythms and slightly worse with metric simple
rhythms. The three-way interaction between group, session, and
metricality did not reach significance (p > 0.1).
Analysis of only the data from participants with PD shows
that metric simple rhythms were discriminated better than metric

Analyses

Rhythm discrimination scores (proportion of correct trials) were
initially analyzed in a 2 × 2 × 2 mixed analysis of covariance
(ANCOVA) with the between-subjects factor of group (PD vs.
control), and the within-subject factors of session (first vs. second
session, also corresponding to OFF vs. ON medication for the
participants with PD) and metricality of rhythms (metric simple
vs. metric complex), and including the covariates musical training (years) and education level (both mean-centered separately
for the two groups). Analyses were repeated without covariates
that were non-significant and/or did not interact with other factors in the initial analysis.
As our primary research interest was the relationship between
beat perception and dopaminergic medication [known to influence cognition in PD; (30)], and because we were unable to test
the healthy controls ON medication, we conducted a separate
2 × 2 ANCOVA on the PD patient data alone. This ANCOVA
included the within-subject factors medication (OFF vs. ON) and
metricality (metric simple vs. metric complex), and the covariate
of MDS-UPDRS (subscale III, off medication, mean-centered).
Furthermore, as only a subset of trials from the previous 2009
study (12) were used in the discrimination task (due to limitations of testing time), data from the 2009 study were reanalyzed
to include only the subset of trials that were used in this current
study. Results from the 2009 study and current study (ON and
OFF medication, separately) were compared using independent
samples t tests.

Frontiers in Neurology | www.frontiersin.org

FIGURE 2 | Mean rhythm discrimination scores (adjusted for musical
training and education) collapsed across rhythm type for both
groups, in both sessions. Error bars indicate ± 1 SEM.
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complex rhythms [main effect of metricality, F(1,69) = 29.81,
p < 0.001, η2p = 0.302], as is evident in Figure 3. The effect of
metricality was larger when participants were ON medication compared to OFF medication [interaction of metricality
and medication, one-tailed, as the direction of differences was
hypothesized, F(1,69) = 2.77, p = 0.050, η2p = 0.039 ]. A paired
t-test of the difference scores (metric simple minus metric
complex, adjusted for UPDRS) confirmed a significantly greater
difference while ON vs. OFF medication [t(70) = 1.69, p = 0.048].
Follow-up t tests indicated that metric simple scores numerically
increased and metric complex scores numerically decreased from
OFF to ON sessions, although neither change was statistically
significant (p > 0.05).
Movement Disorders Society Unified Parkinson’s Disease
Rating Scale scores (off medication) significantly covaried with
overall discrimination performance [F(1,69) = 11.49, p = 0.001,
η2p = 0.143], as shown in Figure 4. MDS-UPDRS scores and mean
discrimination scores (averaged over sessions and metricalities)
negatively correlate (rSp = −0.32, p = 0.007). Although there was
no significant interaction between MDS-UPDRS, medication,
and task performance, exploratory analysis showed that performance negatively correlated with MDS-UPDRS scores both
OFF and ON medication (rSp = −0.28, p = 0.020 and rSp = −0.36,
p = 0.002, respectively).
We compared the results from our current participants with
PD to the results of the 2009 study using the same task (with previous data recalculated to include only the same trials used in the
present study). The 2009 sample was participants with PD, ON
medication with one session of testing [n = 15; (12)]. The current
ON medication sample was numerically more similar to the 2009
sample (also ON medication) than to the current OFF medication
sample. Overall, however, independent samples t tests comparing
the 2009 sample and the current sample ON and OFF medication
(separately) show no statistically significant differences (p > 0.05)
between discrimination scores for either metric simple or metric
complex rhythms (see Figure 5). Thus, when including identical
trials between the 2009 sample and the current sample, the two
groups of patients did not differ in performance.

FIGURE 3 | Mean rhythm discrimination scores (adjusted for musical
training and education) for both groups, in both sessions, and for
both metrical types of rhythms.

FIGURE 4 | MDS-UPDRS scores and rhythm discrimination scores
from participants with PD (discrimination scores are collapsed over
OFF and ON medication conditions).

Beat Alignment Test

Performance on the BAT did not differ between groups, or
between sessions (see Figure 6). BAT scores were not associated
with musical training or education, or MDS-UPDRS scores in
participants with PD. Furthermore, BAT scores did not correlate
with mean discrimination scores (p > 0.05). When analyzing data
from participants with PD alone, we found no effect of medication or interactions involving medication (p > 0.05).

DISCUSSION
Overall, the rhythm discrimination task was sensitive to timing deficits in PD: participants with PD performed worse than
control participants, and participants more severely affected by
PD (those with higher MDS-UPDRS scores) did worse than those
less affected. Furthermore, control participants improved over
the two sessions while participants with PD did not, suggesting
that in addition to a deficit in timing, they may be less able to

FIGURE 5 | Mean rhythm discrimination scores (unadjusted) from the
current sample of participants with PD (OFF and ON dopaminergic
medication) and from a previous study (ON medication only, and
recalculated to include only the trials used in the current study).
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Regarding the discrimination task, we found mixed results.
Contrary to our expectation, we did not see a clear deficit in beat
perception associated with PD. Participants with PD performed
better on the task for metric simple (beat-based) rhythms
than for metric complex (non-beat-based) rhythms, similar
to control participants. This is at odds with the finding from a
previous study that used the same two types of rhythms in the
same rhythm discrimination task, showing that the beat-based
advantage (superior discrimination of metric simple rhythms)
was significantly reduced in PD compared to controls. However,
when results from the previous study were recalculated to include
only the exact same trials used in the current study, the difference in performance between metric simple and metric complex
rhythms increased, and closely resembled that of the current
data (see Figure 5), suggesting that our current study did indeed
replicate the previous results. Moreover, the previous study’s
recalculated data most closely resembles the ON medication
data from the current study. This is notable as participants in the
previous study were ON medication. The dependence of performance on the specific trials included demonstrates a potential
limitation of discrimination tasks: performance is dependent
not just on condition differences (rhythms are easier to encode
and maintain when participants perceive a beat, therefore performance is generally better for beat-based rhythms) but also
the specific nature of the discrimination being made. The task
required participants to detect whether a change occurred in the
rhythm, and the change, when present, was always a transposition (or swapping) of two time intervals. For example, the rhythm
211314 could become 211134. Some transpositions are easier to
detect than others. Changes to the beginning or end of a rhythm
are easier to detect than those in the middle because of primacy
and recency effects (36). In addition, transposition of disparate
intervals (e.g., 3 and 1) may be easier to detect than transposition
of more similar intervals (e.g., 3 and 4). Thus, by reducing the
number of trials selected for the current study, the results could
be more influenced by these trial-specific differences that are not
related to beat perception, but are instead related to the specific
nature and location of the change in the rhythm. However, as
the current results do not differ from the previous results (which
used a much larger set of trials) when reanalyzed to include
only the same trials, we feel it reasonable to interpret the current findings as replicating the previous finding that beat-based
timing is impaired in PD, although trial selection influenced the
exact pattern of results. Further support for a beat-based timing
impairment needs to be acquired. This may be best accomplished
by using different tasks, such as rhythm reproduction that do not
have the limitations present in discrimination tasks.
For participants with PD, the difference in discrimination
performance between metric simple and metric complex
rhythms increased when ON vs. OFF dopaminergic medication.
The data therefore suggest that medication influences beat-based
timing in PD, although the pattern of the influence is complex.
In particular, the worsening of performance for metric complex
(non-beat-based) rhythms was unexpected. The improvement of
performance for beat-based rhythms may be due to dopaminergic
medication improving basal ganglia function, as they are thought
to play a critical role in beat perception. Another possibility is

FIGURE 6 | Mean scores (proportion of correct trials) for the Beat
Alignment Test. Error bars indicate ± 1 SEM.

learn from repetition of the timing task. Although we did not
expect this result, and do not consider it a primary finding of the
study, it is consistent with previous evidence of learning deficits
in PD. For example, patients with PD show less consolidation
than controls after learning a motor control task (31), and slower
re-learning after disruption of a previously learned motor task
(32). Moreover, dopaminergic medication can change the nature
of learning in PD (33–35), possibly contributing to the lack of
improvement in discrimination task performance from session 1
(OFF medication) to session 2 (ON medication) in PD. However,
as the repetition of the task is confounded with medication
status in participants with PD (the first session was always OFF
medication, followed by ON medication in the second session),
we cannot fully disentangle effects of repetition and medication
in participants with PD.
The BAT was not sensitive to timing deficits in PD, as performance on the task by control participants and those with PD
did not significantly differ. The additional information in real
music may give listeners with PD sufficient cues regarding the
beat, such that beat-based timing deficits do not impair task
performance. In addition to the other musical cues to the beat
that are present in the BAT, participants compare simultaneously
presented sequences (the beat in the musical stimulus, and the
overlaid tone sequence). The discrimination task, by comparison,
requires a memory-based judgment, which requires the encoding, rehearsal, and retrieval of a rhythm. These processes involve
the internal generation of rhythms, which is supported by the
presence of temporal structure, such as the beat. Thus, the difference in cognitive processes required by the BAT and the rhythm
discrimination task may underlie the difference in findings
between tasks regarding the particular nature of timing deficits in
PD. Consistent with this interpretation, performance on the BAT
and discrimination task did not correlate, suggesting that these
tasks are indeed sensitive to different aspects of beat perception,
and rely on different underlying cognitive processes. Although
BAT performance was numerically better for control participants
than participants with PD, the large sample sizes suggest that any
potential difference between patients and controls is small.
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that dopaminergic medication biases participants to search for
a beat structure. This bias would improve performance for beatbased rhythms, in which a beat structure can be detected, and
therefore searching for it is beneficial, but the same bias would
worsen performance for metric complex rhythms, in which the
beat structure is difficult to find, and attempting to search for it
distracts from using another, better, strategy to remember the
rhythms. As mentioned above, task repetition (first vs. second
session) is confounded with medication (OFF vs. ON); however,
the metricality-dependent change in performance (improved
performance for metric simple rhythms and worsened performance for metric complex rhythms) is less likely due to repetition
than to medication. An expected effect of repetition would be
improved performance for one or both types of rhythms, but
not worse performance. As such, we interpret the overall lack of
improvement at the task as a deficit in learning the task (compared to control participants’ overall improvement from the first
to second session), but the different direction of performance
change for metric simple and metric complex rhythms as an effect
of medication on beat-based timing.
Overall, these data present further evidence that timing is
impaired in individuals with PD (and worsens with severity of

the disease) that beat-based timing may be particularly impaired
in PD, as we replicated findings from Grahn and Brett (12), which
used a more complete set of trials (less subject to trial-specific
effects) to show a lack of beat-based advantage, and that, consistent with previous work (17), dopaminergic medication may
improve beat-based timing in PD.
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